Mark Corbett, MD

Fractional exhaled nitric oxide levels predicted treatment response to dupilumab among patients who had uncontrolled moderate to severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

People born between January and June in Finland experienced a higher risk for adult-onset asthma than people born later in the year, with a stronger risk among people with atopic asthma, according to a letter published in Asthma.

People exposed to sensitizers and irritants on the job faced greater risks for current adult-onset asthma and uncontrolled asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Mark L. Corbett, MD, FAAAAI, FACAAI, considered medical school early in college before switching to chemical engineering, but that career path did not last.

Omalizumab effectively treated chronic cold urticaria and prevented further episodes of anaphylaxis, according to a single-center study published in The Journal of Allergy and Clinical Immunology: In Practice.

Dupilumab effectively treated nasal polyposis with minimal toxicity among treatment-refractory patients in a real-world setting, according to results of a retrospective cohort study published in Annals of Allergy, Asthma & Immunology.

The frequency of severe COVID-19 does not appear to differ between those with and those without atopic diseases, according to research presented at this year’s virtual American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

Patients with asthma who sleep 5 hours or less per night may be at an increased risk for asthma attacks compared with those who sleep 6 to 8 hours per night, according to research published in the Annals of Allergy, Asthma and Immunology.